Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $10,242 | $8,857 | $6,560 | $10,876 |
Gross Profit | 10,242 | 8,857 | 6,560 | 10,876 |
EBITDA | -137,018 | -121,170 | -97,851 | -82,552 |
EBIT | -137,632 | -122,291 | -98,539 | -83,273 |
Net Income | -125,749 | -112,452 | -98,539 | -83,273 |
Net Change In Cash | 10,242 | 8,857 | 6,560 | 10,876 |
Free Cash Flow | -93,754 | -89,077 | -76,137 | -90,829 |
Cash | 261,452 | 272,589 | 157,522 | 112,825 |
Basic Shares | 102,944 | 92,061 | 88,699 | 88,582 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $218,710 | $7,000 | $23,385 | $50,931 |
Gross Profit | -95,994 | 3,166 | 19,377 | 50,931 |
EBITDA | -154,720 | -270,643 | -108,953 | -60,401 |
EBIT | -159,313 | -274,477 | -112,961 | -62,502 |
Net Income | -113,698 | -274,477 | -112,961 | -54,808 |
Net Change In Cash | 218,710 | 7,000 | 23,385 | 50,931 |
Cost of Revenue | -23,414 | |||
Free Cash Flow | -73,466 | -251,441 | -117,592 | -90,618 |
Cash | 112,825 | 84,378 | 157,018 | 68,632 |
Basic Shares | 88,485 | 81,678 | 57,519 | 41,444 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$1.22 |
2026-06-30 | -$1.22 |
2026-03-31 | -$1.11 |
2025-12-31 | -$0.94 |